| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615358 | Journal of Clinical Lipidology | 2017 | 26 Pages |
Abstract
In virologically suppressed individuals with HIV infection, atorvastatin did not significantly decrease levels of soluble or cellular biomarkers of immune activation and inflammation but resulted in robust reductions in LDL cholesterol, oxLDL, and lipoprotein-associated phospholipase A2, biomarkers associated with cardiovascular risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Daniel E. DO, PhD, Ronald J. PhD, Ellen S. MSc, Nicholas T. PhD, Sally MD, Jordan E. MD, Michael M. MD, Karin L. MD, Judith A. MD,